PIZZUTI DANA (Chief Development Officer) sold 7.0% of their position (5K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $213.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/5/2025ACC: 0001628280-25-049671
Officer· Chief Development Officer
Since Sep 2022
-5K
Net shares
Net seller
$213.3K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5K
Price / share
$16.89
Trade value
$84.45K
% of position
7.5%
11/3/2025
66.27K→71.27K
Common Stock
Direct
Shares
−4.90K
Price / share
$42.65
Trade value
$208.99K
% of position
6.9%
11/3/2025
71.27K→66.37K
Common Stock
Direct
Shares
−100.00
Price / share
$43.27
Trade value
$4.33K
% of position
0.2%
11/3/2025
66.37K→66.27K
Total
Net shares
+0.00
Net value
-$128.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2025 | M · Option Exercise | +5K | $16.89 | $84.45K | 7.5% | 66.27K | 71.27K |
| Common Stock Direct | 11/3/2025 | S · Sale | −4.90K | $42.65 | $208.99K | 6.9% | 71.27K | 66.37K |
| Common Stock Direct | 11/3/2025 | S · Sale | −100.00 | $43.27 | $4.33K | 0.2% | 66.37K | 66.27K |
| Total | +0.00 | -$128.86K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
16.89
Held after
74.04K
Exercisable
—
11/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 11/3/2025 | M · Option Exercise | −5K | 16.89 | — | 74.04K |